InvestorsHub Logo
Followers 2
Posts 925
Boards Moderated 0
Alias Born 06/02/2012

Re: None

Thursday, 10/12/2023 9:41:21 PM

Thursday, October 12, 2023 9:41:21 PM

Post# of 14941
Hmm, more PR. This is something quite different. A website, Prosayla, sponsored by the ISSWSH, which is targeting to be "the trusted educational resource for the care & treatment of female sexual health." Check out the first condition, vestibulodynia, where testosterone gel is a recommended treatment. I have not looked at the rest of the site.

Prosayla

Who knows if we see a reincarnation of Libigel in the next few months, but the stage is most certainly set. The distribution system is well in place with numerous hormone therapy clinics now established across the country. There is support from the ISSWSH that testosterone is a viable treatment option for women. There are resources now in place for training and knowledge-sharing like Prosayla. Lastly, we are about to see ten years of clinical data published. At a minimum they can validate the safety of testosterone for women for its various uses. Ideally, we will see its medical benefits for cardiac disease and breast cancer.

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News